What are accelerator terms like — and should I sign them?
By SuLe · Updated 10 May 2026
Accelerators typically take around 5–10% of your equity — or invest via a SAFE or ASA — in return for cash plus a fixed-term programme. The terms are usually standardised across a cohort, so the real decision is whether to join at all; scrutinise the equity-to-cash ratio, follow-on rights, information rights and any unusual vetoes.
Key facts
- Accelerators commonly take roughly 5–10% equity (or invest via a SAFE/ASA) for cash plus their programme.
- Terms are largely standardised and often barely negotiable — the choice is take-it-or-leave-it.
- What to scrutinise: the equity-to-cash ratio, follow-on rights, information rights, and unusual vetoes.
- Some accelerators use warrants — a right to buy shares later — which is deferred dilution to model now.
- A programme's network and credibility can outweigh the equity cost; a weak one rarely does.
What do accelerator terms usually look like?
The typical shape is a fixed programme — mentoring, workshops, a demo day — plus a modest cash investment, in exchange for a slice of equity commonly in the 5–10% range. Some accelerators issue shares directly; others invest through a SAFE or an ASA that converts at your next round.
The exact percentage and cash amount vary by programme and stage. The number that matters is the ratio: how much equity you give up for how much cash and value you actually receive.
Because these figures move between programmes, treat any percentage as typical rather than fixed, and read your specific offer on its own terms.
Are the terms negotiable?
Usually not much. Accelerators run cohorts on standardised paperwork precisely so they can process many startups on identical terms, which means line-by-line negotiation is rarely on offer.
That does not make you powerless — it just moves your leverage. The decision point is whether to accept the programme as a package, not whether to redraft it. You can always read carefully and decline.
If a term is genuinely unusual — a broad veto, an aggressive follow-on right — it is worth raising, but expect "these are our standard terms" as the answer.
What should you scrutinise before signing?
Four things carry more weight than the headline percentage. The equity-to-cash ratio tells you what you are really paying. Follow-on rights determine whether the accelerator can claim part of your future rounds.
Information rights set what you must share and how often. And any unusual vetoes or consent rights can quietly hand the accelerator influence over decisions well beyond the programme — those matter most of all.
A warrant — a right to buy shares later at a set price — is another common feature and a form of deferred dilution. Model any warrant into your cap table now so a future raise does not surprise you. [More: What is a warrant and why do accelerators use them?]
| Term | Why it matters | What to check |
|---|---|---|
| Equity-to-cash ratio | The true price of the programme | Is the value received worth the stake given? |
| Follow-on rights | Access to your future rounds | Pro-rata only, or something broader? |
| Information rights | Ongoing reporting burden | Frequency and scope |
| Vetoes / consent rights | Control beyond the programme | Any decision the accelerator can block? |
| Warrants | Deferred dilution | Strike price, quantity, trigger |
Is the equity worth it?
That is a commercial judgement, not a legal one, and the honest answer is: it depends on the programme. A top-tier accelerator's network, credibility and follow-on capital can be worth far more than the equity it costs.
A weaker programme charging the same stake rarely is. Look at outcomes for past cohorts, the quality of the network, and whether the cash meaningfully extends your runway.
Weigh that against permanent dilution and any control terms. The equity is gone for good; the programme lasts a few months — so the network and follow-on access have to justify it.
Worked example
Chloe runs a climate SaaS startup and is offered a place in an accelerator: £100,000 for 7% of the company, invested as issued shares, plus a 12-week programme and demo day. The paperwork also includes a small warrant and standard information rights.
Chloe checks the ratio: 7% for £100,000 implies a roughly £1.43m post-money value on the equity alone, before valuing the programme. She confirms the follow-on right is limited to pro-rata, not a broader claim, and models the warrant into her cap table so her seed round maths already reflects it.
The terms are presented as standard and non-negotiable. Because the accelerator's network fits her sector and the control terms are light, Chloe joins — eyes open, cap table updated.
Where founders go wrong
Fixating on the percentage
— a modest stake with a broad veto or aggressive follow-on right can cost you more control than a slightly larger clean stake.Ignoring warrants
— deferred share rights are real dilution; model them into the cap table before your next raise.Assuming the brand guarantees value
— check actual cohort outcomes and network fit, not just the logo.Skipping the read because "it's standard"
— standardised does not mean harmless; know exactly what you are signing.
Related questions
How much equity do accelerators take?
Accelerators commonly take around 5–10% for cash plus their programme, sometimes investing via a SAFE or ASA rather than issued shares. The exact figure varies by programme, so weigh the equity given up against the cash and value you actually receive.
Are accelerator terms negotiable?
Usually not much. Most accelerators run standardised terms across a cohort, so the practical decision is take-it-or-leave-it. You can still read carefully and walk away — the leverage is in choosing whether to join, not in redrafting the deal.
What should I scrutinise before signing?
The equity-to-cash ratio, any follow-on investment rights, information rights, and unusual vetoes or consent rights. A right that lets the accelerator block or heavily influence future rounds matters far more than the headline percentage.
Do accelerators use warrants?
Some do. A warrant gives the accelerator the right to buy shares later at a set price, which is a form of deferred dilution. Model it into your cap table so a future raise does not surprise you. [More: What is a warrant and why do accelerators use them?]
Will an accelerator stake affect my next round?
It can. Follow-on rights, information rights and any consent provisions travel into your next raise, and a messy or unusually founder-unfriendly accelerator deal can become a talking point in diligence. Keep the paperwork clean and standard.
Accelerator terms are usually take-it-or-leave-it, but "standard" still hides follow-on rights, vetoes and warrants that shape your cap table for years. A SuLe solicitor can read the offer, flag anything unusual, and tell you what it means for your next round before you commit. Book a free consultation with a startup solicitor to check the terms in context.
Keep reading: What is a warrant and why do accelerators use them? · How is a Series A different from a seed round legally? · What is a cap table and how do I keep it clean? · What is an advance subscription agreement (ASA)? · What are pro-rata rights? · What extra due diligence do institutional VCs run at Series A?
Primary sources: Companies Act 2006 · BVCA — British Private Equity & Venture Capital Association
